Abhignyan Nagesetti
Overview
Explore the profile of Abhignyan Nagesetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim F, Lei T, Fernandez G, Lopez N, Chu A, Valiente A, et al.
Analyst
. 2022 Oct;
147(23):5283-5292.
PMID: 36269058
The rate-limiting step for diagnostics development is the discovery and validation of biomarker analytes. We describe a new analyte-agnostic and label-free approach based on colorimetric reactions involving type I polymerization...
2.
Nagesetti A, Dulikravich G, Orlande H, Colaco M, McGoron A
Int J Numer Method Biomed Eng
. 2021 Jun;
37(8):e3504.
PMID: 34151543
Drug delivery to tumors suffers from poor solubility, specificity, diffusion through the tumor micro-environment and nonoptimal interactions with components of the extracellular matrix and cell surface receptors. Nanoparticles and drug-polymer...
3.
Nguyen T, Gao J, Wang P, Nagesetti A, Andrews P, Masood S, et al.
Neurotherapeutics
. 2021 Jun;
18(3):2091-2106.
PMID: 34131858
Wireless and precise stimulation of deep brain structures could have important applications to study intact brain circuits and treat neurological disorders. Herein, we report that magnetoelectric nanoparticles (MENs) can be...
4.
Nagesetti A, McGoron A
Colloids Surf B Biointerfaces
. 2018 Jul;
170:663.
PMID: 29986262
No abstract available.
5.
Stewart T, Nagesetti A, Guduru R, Liang P, Stimphil E, Hadjikhani A, et al.
Nanomedicine (Lond)
. 2018 Jan;
13(4):423-438.
PMID: 29345190
Aim: We studied externally controlled anticancer effects of binding tumor growth inhibiting synthetic peptides to magnetoelectric nanoparticles (MENs) on treatment of glioblastomas. Methods: Hydrothermally synthesized 30-nm MENs had the core-shell...
6.
Nagesetti A, Rodzinski A, Stimphil E, Stewart T, Khanal C, Wang P, et al.
Sci Rep
. 2017 Oct;
7(1):14137.
PMID: 29074985
A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
7.
Nagesetti A, Srinivasan S, McGoron A
J Photochem Photobiol B
. 2017 Aug;
174:209-216.
PMID: 28800509
A novel pegylated multifunctional probe of Ormosil nanoparticles (PEGCDSIR820) loaded with Near Infrared dye (NIR; IR820) and a chemotherapeutic drug, Doxorubicin (DOX) was developed for cancer theranostic applications. PEGCDSIR820 nanoparticles...
8.
Hadjikhani A, Rodzinski A, Wang P, Nagesetti A, Guduru R, Liang P, et al.
Nanomedicine (Lond)
. 2017 Jul;
12(15):1801-1822.
PMID: 28705034
Aim: The biodistribution and clearance of magnetoelectric nanoparticles (MENs) in a mouse model was studied through electron energy dispersive spectroscopy. Materials & Methods: This approach allows for detection of nanoparticles...
9.
Nagesetti A, Rodzinski A, Stimphil E, Stewart T, Khanal C, Wang P, et al.
Sci Rep
. 2017 May;
7(1):1610.
PMID: 28487517
Magnetoelectric (ME) nanoparticles (MENs) intrinsically couple magnetic and electric fields. Using them as nuclear magnetic resonance (NMR) sensitive nanoprobes adds another dimension for NMR detection of biological cells based on...
10.
Nagesetti A, McGoron A
Colloids Surf B Biointerfaces
. 2016 Sep;
147:492-500.
PMID: 27614237
We report a novel system of organically modified silica nanoparticles (Ormosil) capable of near infrared fluorescence and chemotherapy with adjuvant hyperthermia for image guided cancer therapy. Ormosil nanoparticles were loaded...